Review
Copyright ©The Author(s) 2015.
World J Diabetes. Dec 25, 2015; 6(18): 1345-1354
Published online Dec 25, 2015. doi: 10.4239/wjd.v6.i18.1345
Figure 4
Figure 4 Schematic representation of the endocrine loops between bone and pancreas, and adipose tissue. Insulin signaling stimulates the expression of osteocalcin and osteoblastic differentiation via inhibiting Twist2, an inhibitor of Runx2, as well as FoxO1, resulting in accumulation of carboxylated osteocalcin in bone matrix. Adiponectin also stimulates osteocalcin expression and the differentiation of osteoblasts via AMP-activated protein kinase (AMPK) signaling pathway. Both insulin and adiponectin activate osteoclasts and accelerate bone turnover via increasing the ratio of RANKL/OPG. Activated osteoclasts decarboxylate bone matrix-embedded osteocalcin, and then undercarboxylated osteocalcin (ucOC) is released into the circulation. UcOC stimulates the expression of insulin in pancreas and of adiponectin in adipose tissue. OST-PTP: Osteotesticular protein tyrosine phosphatase; IR: Insulin resistance.